BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 14, 2016
View Archived Issues
AS03-adjuvanted GlaxoSmithKline H7N9 pandemic influenza vaccine induces robust antibody responses
Read More
REDUCE-IT study of Amarin's Vascepa to continue as planned
Read More
Medicines for Malaria Venture initiates first-in-human trial of P-218
Read More
Circle Pharma and Pfizer enter agreement to build screening library of macrocyclic peptides
Read More
Bioblast Pharma reports results from extension study of trehalose in OPMD
Read More
Voyager Therapeutics enters collaboration to advance VY-HTT01 program
Read More
Semma Therapeutics receives grant for personalized cell therapy for diabetes
Read More
Phase II study of Flex Pharma's FLX-787 in ALS begins
Read More
FDA awards fast track designation to Aptinyx's NYX-2925
Read More
Ligand Pharmaceuticals initiates phase II study of LGD-6972
Read More
AmpliPhi Biosciences's AB-SA01 well tolerated in phase I study
Read More
Oxford Gene Technology launches new FISH probes for lung cancers
Read More
MMRF and Memorial Sloan Kettering collaborate on minimal residue disease trial
Read More
ANA positivity combined with anti-DFS70 negativity may be associated with CTD in NSIP patients
Read More
Dual GLP-1R/glucagon receptor agonist MOD-6031 enters phase I development for obesity
Read More
Morphotek and Fox Chase Cancer Center enter research agreement
Read More
European Commission approves Cabometyx for advanced renal cell carcinoma
Read More
CDRD launches new company developing novel rapid sepsis diagnostic
Read More
Cellectar Biosciences' CLR-131 to be evaluated in head and neck cancers
Read More
BioChaperone Combo reduces postprandial glucose and hyperglycemia risk in type 1 diabetes
Read More
MicroRNA 132 can be targeted to improve pressure-induced heart failure
Read More
Nanobiotix files for approval of NBTXR-3 in Europe
Read More
Hexanal shows potential as an inflammation biomarker
Read More
Bayer's emodepside granted U.S. orphan status for onchocerciasis
Read More
5-HETE and 5-oxoETE show potential for OSA screening
Read More